¼¼°èÀÇ ±Þ¼º±â ÀÇ·á¿ë ´Ïµé¸®½º Ä¿³ØÅÍ ½ÃÀå
Acute Care Needleless Connectors
»óǰÄÚµå : 1655565
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 02¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 226 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,133,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,399,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¼¼°èÀÇ ±Þ¼º±â ÀÇ·á¿ë ´Ïµé¸®½º Ä¿³ØÅÍ ½ÃÀåÀº 2030³â±îÁö 23¾ï ´Þ·¯¿¡ µµ´Þ

2024³â¿¡ 14¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â ¼¼°èÀÇ ±Þ¼º±â ÀÇ·á¿ë ´Ïµé¸®½º Ä¿³ØÅÍ ½ÃÀåÀº ºÐ¼® ±â°£ÀÎ 2024-2030³â¿¡ CAGR 9.1%·Î ¼ºÀåÇϸç, 2030³â¿¡´Â 23¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ ¸®Æ÷Æ®¿¡¼­ ºÐ¼®ÇÑ ºÎ¹®ÀÇ ÇϳªÀÎ ´Ü¼ø ´Ïµé¸®½º Ä¿³ØÅÍ´Â CAGR 11.0%¸¦ ±â·ÏÇϸç, ºÐ¼® ±â°£ Á¾·á±îÁö 12¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. º¹ÀâÇÑ ´Ïµé¸®½º Ä¿³ØÅͺι®ÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£¿¡ CAGR 7.2%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº ÃßÁ¤ 3¾ï 8,750¸¸ ´Þ·¯, Áß±¹Àº CAGR 8.4%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ ±Þ¼º±â ÀÇ·á¿ë ´Ïµé¸®½º Ä¿³ØÅÍ ½ÃÀåÀº 2024³â¿¡ 3¾ï 8,750¸¸ ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ÀÇ °æÁ¦´ë±¹ÀÎ Áß±¹Àº 2030³â±îÁö 3¾ï 4,990¸¸ ´Þ·¯ÀÇ ½ÃÀå ±Ô¸ð¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ºÐ¼® ±â°£ÀÎ 2024-2030³âÀÇ CAGRÀº 8.4%ÀÔ´Ï´Ù. ±âŸ ÁÖ¸ñÇØ¾ß ÇÒ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£ Áß CAGRÀº °¢°¢ 8.7%¿Í 7.3%·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR 7.1%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼¼°èÀÇ ±Þ¼º±â ÀÇ·á¿ë ´Ïµé¸®½º Ä¿³ØÅÍ ½ÃÀå - ÁÖ¿ä µ¿Çâ°ú ÃËÁø¿äÀÎ Á¤¸®

±Þ¼º±â ÀÇ·á¿ë ´Ïµé¸®½º Ä¿³ØÅͶõ ¹«¾ùÀ̸ç, ¿Ö Áß¿äÇѰ¡?

±Þ¼º±â ÀÇ·á¿ë ´Ïµé¸®½º Ä¿³ØÅÍ´Â ÀÇ·á ÇöÀå¿¡¼­ Á¤¸Æ°ü, Ä«Å×ÅÍ ¹× ±âŸ ÁÖÀÔ ½Ã½ºÅÛÀ» ¹Ù´Ã ¾øÀÌ ¿¬°áÇÏ¿© ¹Ù´Ã¿¡ Âñ¸®´Â ¼Õ»ó°ú °¨¿°ÀÇ À§ÇèÀ» ÁÙÀÌ´Â µ¥ »ç¿ëµÇ´Â Áß¿äÇÑ ÀÇ·á±â±âÀÔ´Ï´Ù. ÀÇ·áÁøÀÌ ¾ÈÀüÇÏ°í ¹«±ÕÀûÀÎ ¿¬°áÀ» ÅëÇØ ¼ö¾× ÁÖÀÔ, Åõ¾à, äÇ÷À» ÇÒ ¼ö ÀÖµµ·Ï µµ¿ÍÁÝ´Ï´Ù. ´Ïµé¸®½º Ä¿³ØÅÍ´Â º´¿ø ¹× ±Þ¼º±â ÀÇ·á ÇöÀå¿¡¼­ Á¤¸ÆÁÖ»ç ¿ä¹ýÀÇ Ç¥ÁØÀÌ µÇ¾î ȯÀÚÀÇ ¾ÈÀü¼ºÀ» ³ôÀÌ°í ¿À¿°ÀÇ À§ÇèÀ» ÁÙÀÔ´Ï´Ù. ÀÇ·á ½Ã½ºÅÛÀÌ °¨¿° °ü¸®¿Í ȯÀÚ Ä¡·á °á°ú¸¦ °³¼±Çϱâ À§ÇØ ³ë·ÂÇÔ¿¡ µû¶ó °í±Þ ´Ïµé¸®½º Ä¿³ØÅÍ¿¡ ´ëÇÑ ¼ö¿ä´Â Áö¼ÓÀûÀ¸·Î Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

´Ïµé¸®½º Ä¿³ØÅͰ¡ ÀÇ·á ºÐ¾ßÀÇ °¨¿° °ü¸®¿¡ ¾î¶»°Ô ±â¿©Çϴ°¡?

´Ïµé¸®½º Ä¿³ØÅÍÀÇ ÁÖ¿ä ÀåÁ¡ Áß Çϳª´Â º´¿ø ȯ°æ¿¡¼­ ÈçÇÏ°í ½É°¢ÇÑ ÇÕº´ÁõÀÎ Ä«Å×ÅÍ °ü·Ã Ç÷·ù °¨¿°(CRBSI)À» ¿¹¹æÇÏ´Â ¿ªÇÒÀ» ÇÑ´Ù´Â Á¡ÀÔ´Ï´Ù. ÀÌ·¯ÇÑ Àåºñ¿¡´Â Ç×±Õ ÄÚÆÃ ¹× ¹ÐºÀ ½Ã½ºÅÛ°ú °°Àº °í±Þ ¼³°è ±â´ÉÀÌ ³»ÀåµÇ¾î ÀÖÀ¸¸ç, Á¤¸Æ ¶óÀÎ Á¢±Ù½Ã ¿À¿° À§ÇèÀ» ÁÙÀÔ´Ï´Ù. ƯÈ÷ Ç×»ýÁ¦ ³»¼º °¨¿°°ú º´¿ø³» °¨¿°(HAI)¿¡ ´ëÇÑ ¿ì·Á°¡ ³ô¾ÆÁö¸é¼­, °¨¿° ¿¹¹æÀº ÀÇ·á ¼­ºñ½º ÇÁ·Î¹ÙÀÌ´õ¿¡°Ô ÃÖ¿ì¼± ¼øÀ§°¡ µÇ°í ÀÖ½À´Ï´Ù. ¹Ù´ÃÀÇ Çʿ伺À» ÃÖ¼ÒÈ­ÇÏ°í º¸´Ù ¾ÈÀüÇÑ ´ë¾ÈÀ» Á¦°øÇÏ´Â ´Ïµé¸®½º Ä¿³ØÅÍ´Â ÀÇ·áÁøÀÌ ¾ö°ÝÇÑ °¨¿° ¿¹¹æ ÇÁ·ÎÅäÄÝÀ» ÁؼöÇϸ鼭 ȯÀÚÀÇ ¾ÈÀüÀ» Çâ»ó½Ãų ¼ö ÀÖµµ·Ï µ½½À´Ï´Ù.

±â¼úÀÇ ¹ßÀüÀ¸·Î ´Ïµé¸®½º Ä¿³ØÅÍÀÇ ¼³°è´Â ¾î¶»°Ô °³¼±µÇ°í Àִ°¡?

±â¼úÀÇ ¹ßÀüÀº ±Þ¼º±â ÀÇ·á¿ë ´Ïµé¸®½º Ä¿³ØÅÍÀÇ µðÀÚÀΰú ±â´ÉÀ» Å©°Ô Çâ»ó½ÃÄ×½À´Ï´Ù. ÃֽŠĿ³ØÅÍ´Â À¯¼ÓÀ» ³ôÀ̰í, ȯ·ù·®À» ÁÙÀ̸ç, »ç¿ë ÆíÀǼºÀ» Çâ»ó½ÃÄÑ ¸·ÈûÀ̳ª ¸·Èû°ú °°Àº ÇÕº´ÁõÀ» ÁÙÀÌ´Â µ¥ µµ¿òÀÌ µÇ´Â ¼³°è¸¦ °®Ãß°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ ¸¹Àº Ä¿³ØÅÍ´Â Ç×±Õ Æ¯¼ºÀ» °¡Áö°í ÀÖÀ¸¸ç, °¨¿°À» À¯¹ßÇÏ´Â ¹ÚÅ׸®¾Æ¿¡ ´ëÇÑ º¸È£ ÃþÀ» Ãß°¡ÇÕ´Ï´Ù. ¶ÇÇÑ Àç·á °úÇÐÀÇ Çõ½ÅÀ¸·Î ³»±¸¼º°ú »ýüÀûÇÕ¼ºÀÌ ³ôÀº Ä¿³ØÅͰ¡ °³¹ßµÇ¾î Àå½Ã°£ Á¤¸ÆÁÖ»ç ¿ä¹ýÀ» ÇÊ¿ä·Î Çϴ ȯÀÚÀÇ Àå±â »ç¿ë¿¡µµ ¾ÈÀü¼ºÀ» º¸ÀåÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¹ßÀüÀº ƯÈ÷ À§Çèµµ°¡ ³ôÀº ±Þ¼º±â ÀÇ·á ȯ°æ¿¡¼­ ÀÇ·áÁøÀÌ º¸´Ù È¿°úÀûÀÌ°í ¾ÈÀüÇÑ Ä¡·á¸¦ Á¦°øÇÒ ¼ö ÀÖµµ·Ï µ½°í ÀÖ½À´Ï´Ù.

±Þ¼º±â ÀÇ·á¿ë ´Ïµé¸®½º Ä¿³ØÅÍ ½ÃÀåÀÇ ¼ºÀå ¿øµ¿·ÂÀº?

±Þ¼º±â ÀÇ·á¿ë ´Ïµé¸®½º Ä¿³ØÅÍ ½ÃÀåÀÇ ¼ºÀåÀº ÀÇ·á ȯ°æ¿¡¼­ °¨¿° °ü¸®¿¡ ´ëÇÑ °ü½É Áõ°¡, Ä¿³ØÅÍ ¼³°èÀÇ ±â¼úÀû Áøº¸, Àå±âÀûÀÎ Á¤¸ÆÁÖÀÔÀÌ ÇÊ¿äÇÑ ¸¸¼ºÁúȯÀÇ À¯º´·ü Áõ°¡ µî ¿©·¯ °¡Áö ¿äÀο¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù. º´¿ø°ú ÀÇ·á ¼­ºñ½º ÇÁ·Î¹ÙÀÌ´õ´Â º´¿ø³» °¨¿° À§ÇèÀ» ÁÙ¿©¾ß Çϸç, ´Ïµé¸®½º Ä¿³ØÅʹ ȯÀÚ ¾ÈÀüÀ» °³¼±ÇÏ´Â µ¥ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. ÀæÀº ÁÖÀÔÀÌ ÇÊ¿äÇÑ ´ç´¢º´À̳ª ¾Ï°ú °°Àº ¸¸¼ºÁúȯÀÇ ¹ßº´·ü Áõ°¡µµ ÷´Ü ´Ïµé¸®½º Ä¿³ØÅÍ ½Ã½ºÅÛ¿¡ ´ëÇÑ ¼ö¿ä¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ Àç·á ¹× µðÀÚÀÎ Çõ½ÅÀ¸·Î ÀÎÇØ ÀÌ·¯ÇÑ Àåºñ´Â ´õ¿í È¿°úÀûÀÌ°í »ç¿ëÇϱ⠽¬¿öÁ® ±Þ¼º±â ÀÇ·á ÇöÀå¿¡¼­ÀÇ º¸±Þ¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù.

ºÎ¹®

µðÀÚÀÎ(´Ü¼ø ´Ïµé¸®½º Ä¿³ØÅÍ, º¹ÀâÇÑ ´Ïµé¸®½º Ä¿³ØÅÍ) ; & ¸ÞÄ¿´ÏÁò(Æ÷ÁöƼºê À¯Ã¼ ġȯ, ³×°ÅƼºê À¯Ã¼ ġȯ, Á߸³ À¯Ã¼ ġȯ)

Á¶»ç ´ë»ó ±â¾÷ÀÇ ¿¹(ÃÑ 48°Ç)

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå °³¿ä

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

KSA
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Acute Care Needleless Connectors Market to Reach US$2.3 Billion by 2030

The global market for Acute Care Needleless Connectors estimated at US$1.4 Billion in the year 2024, is expected to reach US$2.3 Billion by 2030, growing at a CAGR of 9.1% over the analysis period 2024-2030. Simple Needleless Connectors, one of the segments analyzed in the report, is expected to record a 11.0% CAGR and reach US$1.2 Billion by the end of the analysis period. Growth in the Complex Needleless Connectors segment is estimated at 7.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$387.5 Million While China is Forecast to Grow at 8.4% CAGR

The Acute Care Needleless Connectors market in the U.S. is estimated at US$387.5 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$349.9 Million by the year 2030 trailing a CAGR of 8.4% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 8.7% and 7.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 7.1% CAGR.

Global Acute Care Needleless Connectors Market – Key Trends & Drivers Summarized

What Are Acute Care Needleless Connectors and Why Are They Important?

Acute care needleless connectors are critical medical devices used in healthcare settings to connect IV lines, catheters, and other infusion systems without the need for needles, reducing the risk of needlestick injuries and infections. These devices allow healthcare providers to administer fluids, medications, or draw blood through a secure and sterile connection. Needleless connectors have become a standard part of IV therapy in hospitals and acute care settings, improving patient safety and reducing the risk of contamination. As healthcare systems strive to enhance infection control practices and patient outcomes, the demand for advanced needleless connectors continues to grow.

How Do Needleless Connectors Contribute to Infection Control in Healthcare?

One of the primary benefits of needleless connectors is their role in preventing catheter-related bloodstream infections (CRBSIs), a common and serious complication in hospital settings. These devices incorporate advanced design features, such as antimicrobial coatings and closed systems, to reduce the risk of contamination when accessing IV lines. Infection control has become a top priority for healthcare providers, particularly in light of increasing concerns about antibiotic-resistant infections and hospital-acquired infections (HAIs). By minimizing the need for needles and providing a safer alternative for accessing IV systems, needleless connectors help healthcare professionals improve patient safety while adhering to stringent infection prevention protocols.

How Are Technological Advancements Improving Needleless Connector Design?

Technological advancements have significantly improved the design and functionality of acute care needleless connectors. Modern connectors are designed with improved flow rates, lower reflux volumes, and enhanced ease of use, which helps reduce complications such as occlusions and blockages. Additionally, many connectors now feature integrated antimicrobial properties that provide an added layer of protection against infection-causing bacteria. Innovations in materials science have also led to the development of more durable and biocompatible connectors, ensuring that they are safe for long-term use in patients requiring extended IV therapy. These advancements are helping healthcare providers deliver more effective and safer care, especially in high-risk acute care environments.

What Is Driving Growth in the Acute Care Needleless Connectors Market?

The growth in the acute care needleless connectors market is driven by several factors, including the rising focus on infection control in healthcare settings, technological advancements in connector design, and the increasing prevalence of chronic diseases requiring long-term IV therapy. Hospitals and healthcare providers are under growing pressure to reduce the risk of hospital-acquired infections, and needleless connectors play a vital role in improving patient safety. The rising incidence of chronic conditions, such as diabetes and cancer, that require frequent intravenous treatments is also driving demand for advanced needleless connector systems. Additionally, innovations in materials and design are making these devices more effective and easier to use, contributing to their widespread adoption in acute care settings.

SCOPE OF STUDY:

The report analyzes the Acute Care Needleless Connectors market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Design (Simple Needleless Connectors, Complex Needleless Connectors); Mechanism (Positive Fluid Displacement, Negative Fluid Displacement, Neutral Fluid Displacement)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 48 Featured) -

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â